The effects of LY2189265, a long-acting glucagon-like...

The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study

G. E. Umpierrez, T. Blevins, J. Rosenstock, C. Cheng, J. H. Anderson, E. J. Bastyr III, for the EGO Study Group
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Year:
2011
Language:
english
Pages:
8
DOI:
10.1111/j.1463-1326.2011.01366.x
File:
PDF, 652 KB
english, 2011
Conversion to is in progress
Conversion to is failed